KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2016 - 2024)

Pacific Biosciences Of California (PACB) has 12 years of Other Non-Current Liabilities data on record, last reported at $18.7 million in Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities rose 2390.01% year-over-year to $18.7 million; the TTM value through Dec 2024 reached $18.7 million, up 2390.01%, while the annual FY2024 figure was $18.7 million, 2390.01% up from the prior year.
  • Other Non-Current Liabilities reached $18.7 million in Q4 2024 per PACB's latest filing, up from $751000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $186.3 million in Q2 2023 and bottomed at $751000.0 in Q4 2023.
  • Average Other Non-Current Liabilities over 5 years is $64.2 million, with a median of $9.9 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Liabilities: soared 22468.75% in 2021, then plummeted 99.6% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $752000.0 in 2020, then skyrocketed by 22468.75% to $169.7 million in 2021, then crashed by 99.23% to $1.3 million in 2022, then plummeted by 42.23% to $751000.0 in 2023, then soared by 2390.01% to $18.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Liabilities were $18.7 million in Q4 2024, $751000.0 in Q3 2024, and $751000.0 in Q2 2024.